Hong et al. demonstrated that the development of diabetic nephropathy, glomerular angiogenesis, and podocyte loss was decreased in streptozotocin-induced diabetic mice with LRG1 deficiency [127]. This evidence concerns the gene LRG1 and diabetic kidney disease.